SUPPORT-T for Idiopathic Pulmonary Fibrosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new digital program called SUPPORT-T, designed to help individuals with Progressive Pulmonary Fibrosis (PPF) and their caregivers manage the condition more effectively. SUPPORT-T includes a 9-week digital app with nurse guidance and virtual support groups over a year. The trial will compare the effectiveness of SUPPORT-T with standard care to determine its potential usefulness in future larger trials. Individuals diagnosed with PPF who speak English or Spanish may be suitable candidates for this study. As an unphased trial, participants can contribute to innovative research that could shape future care strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the SUPPORT-T intervention is safe?
Research has shown that telehealth programs like SUPPORT-T can be safe and well-liked by patients. For instance, one study found that a similar tele-nursing program increased satisfaction among patients with pulmonary fibrosis. These patients felt better prepared and more confident in managing their condition.
Another study found that breathing exercises provided through telehealth reduced symptoms such as shortness of breath, anxiety, and depression in patients with idiopathic pulmonary fibrosis. These findings suggest that SUPPORT-T, where a nurse assists participants through a digital platform, could be a safe choice for those seeking extra support in managing their condition.
Overall, evidence indicates that digital programs like SUPPORT-T not only are feasible but also help improve the quality of life for patients with similar conditions.12345Why are researchers excited about this trial?
Researchers are excited about the SUPPORT-T program for idiopathic pulmonary fibrosis (IPF) because it offers a unique telehealth-based approach to patient care. Unlike traditional treatments that often rely on in-person visits and medication, SUPPORT-T emphasizes biweekly telehealth visits and personalized communication through a secure platform. This method allows for real-time monitoring and support from a nurse interventionist, making it a potentially more convenient and responsive option for patients. By integrating technology and direct patient engagement, SUPPORT-T aims to enhance patient experience and potentially improve outcomes in managing IPF.
What evidence suggests that the SUPPORT-T intervention is effective for Progressive Pulmonary Fibrosis?
Research has shown that telehealth programs can increase satisfaction among patients and caregivers. One study found that a tele-nursing program using phone and email consultations improved patient satisfaction. Breathing exercises delivered through telehealth have positively affected symptoms like shortness of breath, anxiety, and depression in patients with lung diseases such as idiopathic pulmonary fibrosis, which causes lung scarring. Although overall health quality showed little change, patients expressed high satisfaction with telehealth. These findings suggest that the SUPPORT-T program, which participants in this trial may receive as part of the intervention arm, could enhance the quality of life for individuals with progressive pulmonary fibrosis.12367
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Progressive Pulmonary Fibrosis (PPF) and their main caregivers. Participants must speak English, have a confirmed PPF diagnosis, and be involved in providing emotional, financial, or physical support to the patient.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the SUPPORT-T digital application guided by a nurse interventionist for 9 weeks
Support Groups
Quarterly virtual support groups are held over one year
Follow-up
Participants are monitored for feasibility and disease preparedness outcomes
What Are the Treatments Tested in This Trial?
Interventions
- SUPPORT-T
Trial Overview
The SUPPORT-T Educational Intervention is being tested. It's a digital palliative care program guided by nurses that includes a 9-week app use and quarterly virtual support groups over one year. The study compares this intervention to Enhanced Usual Care.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants in the intervention arm will have a telehealth preparatory visit scheduled 1 week later (Week 2) with the Study Coordinator and will be provided with the study number to call with questions. SUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and/or Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts). • All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12
* Participants in the enhanced usual care arm will receive printed education materials from the Pulmonary Fibrosis Foundation (PFF) and the nurse interventionist's contact information. * All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Citations
A Pragmatic Tele-Nursing Program Improves Satisfaction of ...
Conclusions: A pragmatic and affordable tele-nursing program, based on direct phone and email consultations, may enhance patient and caregiver ...
SUPPORT-T in Patients With Progressive Pulmonary ...
This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care ...
Feasibility of a telehealth breathing intervention for patients ...
Breathing exercises can positively influence dyspnea, anxiety, depression, and quality of life in patients living with IPF. Abstract. Idiopathic pulmonary ...
Patient and healthcare professional perspectives on ... - PMC
While no significant difference in overall health-related quality was noted, the telehealth program was associated with high patient ...
Exploring the Impact of Telerehabilitation on Physical ...
Idiopathic pulmonary fibrosis (IPF) is the most common and extensively researched ILD, accounting for approximately 20% of all ILD cases.
A Pragmatic Tele-Nursing Program Improves Satisfaction ...
This study supports the integration of a pragmatic and low-complexity tele-nursing model into routine care for patients with pulmonary fibrosis. The ...
Nurse-Led Palliative Care Clinical Trial Improves ...
We assessed the impact of the “A Program of SUPPORT” intervention on knowledge about IPF, disease preparedness and confidence, patient-reported ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.